Peripheral blood neutrophil activation patterns are associated with pulmonary inflammatory responses to lipopolysaccharide in humans

Journal of Immunology

Volumn 176, Issue 12, 2006, Pages 7753-7760

  Abraham, Edward ^a,b,d   Nick, Jerry A ^a   Azam, Tania ^a   Kim, Soo Hyun ^a   Mira, Jean Paul ^c   Svetkauskaite, Daiva ^a   He, Qianbin ^a   Zamora, Marty ^a   Murphy, James ^b   Park, Jong Sung ^a   Overdier, Katherine ^a   Dinarello, Charles A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR RECEPTOR 2;

ACUTE LUNG INJURY; ADULT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; DNA BINDING; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; LUNG FUNCTION; LUNG LAVAGE; MALE; NEUTROPHIL; PATTERN RECOGNITION; PNEUMONIA; PRIORITY JOURNAL;

EID: 33744917518     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.12.7753     Document Type: Article

References (37)

1. Matthay, M. A., G. A. Zimmerman, C. Esmon, J. Bhattacharya, B. Coller, C. M. Doerschuk, J. Floros, M. A. Gimbrone, Jr., E. Hoffman, R. D. Hubmayr, et al. 2003. Future research directions in acute lung injury: summary of a national heart, lung, and blood institute working group. Am. J. Respir. Crit. Care Med. 167: 1027-1035.
2. Abraham, E. 2003. Neutrophils and acute lung injury. Crit. Care Med. 31: S195-S199.
3. Abraham, E., A. Carmody, R. Shenkar, and J. Arcaroli. 2000. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am. J. Physiol 279: L1137-L1145.
4. Chignard, M., and V. Balloy. 2000. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am. J. Physiol. 279: L1083-L1090.
5. Savov, J. D., S. H. Gavett, D. M. Brass, D. L. Costa, and D. A. Schwartz. 2002. Neutrophils play a critical role in development of LPS-induced airway disease. Am. J. Physiol 283: L952-L962.
6. Hollingsworth, J. W., B. J. Chen, D. M. Brass, K. Berman, M. D. Gunn, D. N. Cook, and D. A. Schwartz. 2005. The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am. J. Respir. Crit. Care Med. 171: 806-813.
7. Azoulay, E., M. Darmon, C. Delclaux, F. Fieux, C. Bornstain, D. Moreau, H. Attalah, J. R. Le Gall, and B. Schlemmer. 2002. Deterioration of previous acute lung injury during neutropenia recovery. Crit. Care Med. 30: 781-786.
8. Rinaldo, J. E., and H. Borovetz. 1985. Deterioration of oxygenation and abnormal lung microvascular permeability during resolution of leukopenia in patients with diffuse lung injury. Am. Rev. Respir. Dis. 131: 579-583.
9. Moine, P., R. McIntyre, M. D. Schwartz, D. Kaneko, R. Shenkar, Y. Le Tulzo, E. E. Moore, and E. Abraham. 2000. NF-κβ regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 13: 85-91.
10. Schwartz, M. D., E. E. Moore, F. A. Moore, R. Shenkar, P. Moine, J. B. Haenel, and E. Abraham. 1996. Nuclear factor-κβ is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit. Care Med. 24: 1285-1292.
11. Chen, L. F., and W. C. Greene. 2004. Shaping the nuclear action of NF-κβ. Nat. Rev. Mol. Cell Biol. 5: 392-401.
12. Arnalich, F., E. Garcia-Palomero, J. Lopez, M. Jimenez, R. Madero, J. Renart, J. J. Vazquez, and C. Montiel. 2000. Predictive value of nuclear factor κβ activity and plasma cytokine levels in patients with sepsis. Infect. Immun. 68: 1942-1945.
13. Bohrer, H., F. Qiu, T. Zimmermann, Y. Zhang, T. Jllmer, D. Mannel, B. W. Bottiger, D. M. Stern, R. Waldherr, H. D. Saeger, et al. 1997. Role of NKκβ in the mortality of sepsis. J. Clin. Invest. 100: 972-985.
14. Yang, K. Y., J. J. Arcaroli, and E. Abraham. 2003. Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am. J. Respir. Crit. Care Med. 167: 1567-1574.
15. Yum, H. K., J. Arcaroli, J. Kupfner, R. Shenkar, J. M. Penninger, T. Sasaki, K. Y. Yang, J. S. Park, and E. Abraham. 2001. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J. Immunol. 167: 6601-6608.
16. Blackwell, T. S., T. R. Blackwell, E. P. Holden, B. W. Christman, and J. W. Christman. 1996. In vivo antioxidant treatment suppresses nuclear factor-κβ activation and neutrophilic lung inflammation. J. Immunol. 157: 1630-1637.
17. Nick, J. A., C. D. Coldren, M. W. Geraci, K. R. Poch, B. W. Fouty, J. O'Brien, M, Gruber, S. Zarini, R. C. Murphy, K. Kuhn, et al. 2004. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104: 3878-3885.
18. Park, J. S., D. Svetkauskaite, Q. He, J. Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279: 7370-7377.
19. O'Grady, N. P., H. L. Preas, J. Pugin, C. Fiuza, M. Tropea, D. Reda, S. M. Banks, and A. F. Suffredini. 2001. Local inflammatory responses following bronchial endotoxin instillation in humans. Am. J. Respir. Crit. Care Med. 163: 1591-1598.
20. Suffredini, A. F., H. D. Hochstein, and F. G. McMahon. 1999. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J. Infect. Dis. 179: 1278-1282.
21. Shenkar, R., M. D. Schwartz, L. S. Terada, J. E. Repine, J. McCord, and E. Abraham. 1996. Hemorrhage activates NF-κβ in murine lung mononuclear cells in vivo. Am. J. Physiol 270: L729-L735.
22. Shenkar, R., H. K. Yum, J. Arcaroli, J. Kupfner, and E. Abraham. 2001. Interactions between CBP, NF-κβ, and CREB in the lungs after hemorrhage and endotoxemia. Am. J. Physiol. 281: L418-L426.
23. Lorenz, E., K. L. Frees, and D. A. Schwartz. 2001. Determination of the TLR4 genotype using allele-specific PCR. BioTechniques 31: 22-24.
24. Lorenz, E., J. P. Mira, K. L. Frees, and D. A. Schwartz. 2002. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 162: 1028-1032.
25. Arbour, N. C., E. Lorenz, B. C. Schutte, J. Zabner, J. N. Kline, M. Jones, K. Frees, J. L. Watt, and D. A. Schwartz. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25: 187-191.
26. Schwartz, D. A. 2001. The role of TLR4 in endotoxin responsiveness in humans. J. Endotoxin Res. 7: 389-393.
27. Lorenz, E., M. Jones, C. Wohlford-Lenane, N. Meyer, K. L. Frees, N. C. Arbour, and D. A. Schwartz. 2001. Genes other than TLR4 are involved in the response to inhaled LPS. Am. J. Physiol 281: L1106-L1114.
28. Donnelly, T. J., P. Meade, M. Jagels, H. G. Cryer, M. M. Law, T. E. Hugli, W. C. Shoemaker, and E. Abraham. 1994. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit. Care Med. 22: 768-776.
29. Dunne, A., and L. A. O'Neill. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 171:re3.
30. O'Neill, L. A. 2002. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr. Top Microbiol. Immunol. 270: 47-61.
31. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-κβ. Genes Dev. 18: 2195-2224.
32. Kumar, A., Y. Takada, A. M. Boriek, and B. B. Aggarwal. 2004. Nuclear factor-κβ: its role in health and disease. J. Mol. Med. 82: 434-448.
33. Ku, C. L., K. Yang, J. Bustamante, A. Puel, H. von Berauth, O. F. Santos, T. Lawrence, H. H. Chang, H. Al-Mousa, C. Picard, et al. 2005. Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol. Rev. 203: 10-20.
34. Medvedev, A. E., A. Lentschat, D. B. Kuhns, J. C. Blanco, C. Salkowski, S. Zhang, M. Arditi, J. I. Gallin, and S. N. Vogel. 2003. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med. 198: 521-531.
35. Medvedev, A. E., K. Thomas, A. Awomoyi, D. B. Kuhns, J. I. Gallin, X. Li, and S. N. Vogel. 2005. Cutting edge: expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters normal IRAK-4 interaction with components of the IL-1 receptor complex. J. Immunol. 174: 6587-6591.
36. Picard, C., A. Puel, M. Bonnet, C. L. Ku, J. Bustamante, K. Yang, C. Soudais, S. Dupuis, J. Feinberg, C. Fieschi, et al. 2003. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299: 2076-2079.
37. Park, W. Y., C. W. Frevert, V. A. Wong, and T. R. Martin. 2002. High and low inflammatory response phenotypes in 101 normal human subjects. Chest 121: 87S-88S.